Haemonetics (HAE) Goodwill (2010 - 2026)

Haemonetics has reported Goodwill for 17 years, with the latest figure at $656.4 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill rose 8.62% year-over-year to $656.4 million; the trailing twelve-month figure through Mar 2026 stood at $656.4 million (up 8.62% YoY), and the FY2026 full-year result was $656.4 million, up 8.62% from the prior year.
• Goodwill for Q1 2026 stood at $656.4 million, up from $606.8 million in the prior quarter.
• The five-year high for Goodwill was $656.4 million in Q1 2026, with the low at $465.0 million in Q4 2022.
• Average Goodwill over 5 years is $542.6 million, with a median of $560.0 million recorded in 2023.
• Year-over-year, Goodwill surged 117.25% in 2022 and declined 1.63% in 2025.
• Tracing HAE's Goodwill over 5 years: stood at $466.1 million in 2022, then increased by 19.07% to $555.0 million in 2023, then advanced by 9.06% to $605.3 million in 2024, then grew by 0.26% to $606.8 million in 2025, then advanced by 8.16% to $656.4 million in 2026.
• The last three Goodwill figures came in at $656.4 million (Q1 2026), $606.8 million (Q4 2025), and $606.1 million (Q3 2025), per Business Quant data.

Peer Comparison